JSW
UTHR icon

Journey Strategic Wealth’s United Therapeutics UTHR Stock Holding History

Journey Strategic Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$608K Sell
1,026
-66
-6% -$32.9K 0.02% 293
2025
Q4 		$532K Buy
1,092
+139
+15% +$64.7K 0.01% 296
2025
Q3 		$400K Buy
953
+95
+11% +$31.9K 0.01% 358
2025
Q2 		$247K Buy
+858
New +$256K 0.01% 518
2025
Q1 		– Sell
-646
Closed -$228K – 544
2024
Q4 		$228K Buy
646
+1
+0.2% +$368 0.01% 430
2024
Q3 		$231K Buy
645
+16
+3% +$5.41K 0.01% 423
2024
Q2 		$200K Buy
+629
New +$166K 0.01% 371

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Journey Strategic Wealth's UTHR Position: Q1 2026 in Review

Journey Strategic Wealth reduced its United Therapeutics (UTHR) stake by 6% in Q1 2026, selling an estimated $32.9K and leaving 1,026 shares worth $608K. The position accounts for 0.02% of the portfolio, ranked #293.

Journey Strategic Wealth first reported a position in UTHR in Q2 2024 and has held it in 7 quarters since. 854 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Journey Strategic Wealth held 1,026 shares of United Therapeutics worth $608K as of Q1 2026.
  • Journey Strategic Wealth sold 66 United Therapeutics shares in Q1 2026, an estimated $32.9K.
  • United Therapeutics made up 0.02% of Journey Strategic Wealth's portfolio in Q1 2026, its #293 holding.
  • Journey Strategic Wealth first reported a position in United Therapeutics in Q2 2024 and has held it in 7 quarters since.
  • 854 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.